Boarding Common While Awaiting Acute Pediatric Psychiatric Care
By Elana Gotkine HealthDay Reporter
THURSDAY, Feb. 13, 2025 -- Boarding for pediatric mental health (MH) conditions while awaiting acute psychiatric care is common, with significant variation observed in boarding practice by hospital site, according to a study published online Feb. 13 in Pediatrics.
Kathleen D. Snow, M.D., M.P.H., from Boston Children's Hospital, and colleagues conducted a retrospective cross-sectional study analyzing pediatric MH boarding encounters at 40 tertiary children's hospitals between Jan. 1, 2017, and Dec. 31, 2023. The analysis included children aged 3 to 18 years presenting with a primary psychiatric diagnosis.
Data were included for 100,784 boarding encounters across 40 hospitals between 2017 and 2023. The researchers observed an increase in the median length of stay for boarding encounters, from three to four days; 0.3 percent of children had stays longer than 100 days. There was significant variation seen in boarding practices by hospital site. Older age, government insurance type, increasing medical complexity, specific psychiatric disorder, season of presentation, and discharge disposition to home were associated with prolonged boarding.
"Pediatric MH boarding at acute care hospitals is common and patients are increasingly requiring prolonged stays while awaiting psychiatric disposition, especially those with underlying medical and psychiatric complexity," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Stay up to date on the latest in health — Click here to subscribe to our weekly newsletter!
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-02-14 06:00
Read more

- Ketamine Use Is on the Rise in U.S.
- Perioperative Chemo With FLOT Ups Survival in Resectable Esophageal Cancer
- Weight Loss Boosts Long-Term Health of Kids With Obesity
- Amylyx Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on AMX0114 Phase 1 Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis
- Tris Pharma Announces Positive Results from ALLEVIATE-1 Phase 3 Clinical Trial of Cebranopadol, an Investigational First-in-Class Oral Dual-NMR Agonist, for the Treatment of Moderate-to-Severe Acute Pain
- ASA: Intra-Arterial Tenecteplase Beneficial for Large Vessel Occlusion
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions